Literature DB >> 26291128

Telomere biology: Rationale for diagnostics and therapeutics in cancer.

Philippe Rousseau1, Chantal Autexier1,2.   

Abstract

The key step of carcinogenesis is the malignant transformation which is fundamentally a telomere biology dysfunction permitting cells to bypass the Hayflick limit and to divide indefinitely and uncontrollably. Thus all partners and structures involved in normal and abnormal telomere maintenance, protection and lengthening can be considered as potential anti-cancer therapeutic targets. In this Point of View we discuss, highlight and provide new perspectives from the current knowledge and understanding to position the different aspects of telomere biology and dysfunction as diagnostic, preventive and curative tools in the field of cancer.

Entities:  

Keywords:  alternative lengthening of telomere; cancer diagnostics; cancer therapeutics; shelterin; telomerase; telomere; telomere uncapping

Mesh:

Substances:

Year:  2015        PMID: 26291128      PMCID: PMC4829327          DOI: 10.1080/15476286.2015.1081329

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  56 in total

Review 1.  A new beginning with new ends: linearisation of circular chromosomes during bacterial evolution.

Authors:  J N Volff; J Altenbuchner
Journal:  FEMS Microbiol Lett       Date:  2000-05-15       Impact factor: 2.742

2.  PTOP interacts with POT1 and regulates its localization to telomeres.

Authors:  Dan Liu; Amin Safari; Matthew S O'Connor; Doug W Chan; Andrew Laegeler; Jun Qin; Zhou Songyang
Journal:  Nat Cell Biol       Date:  2004-06-06       Impact factor: 28.824

3.  A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2.

Authors:  Benjamin R Houghtaling; Leanora Cuttonaro; William Chang; Susan Smith
Journal:  Curr Biol       Date:  2004-09-21       Impact factor: 10.834

Review 4.  Telomeric strategies: means to an end.

Authors:  Devanshi Jain; Julia Promisel Cooper
Journal:  Annu Rev Genet       Date:  2010       Impact factor: 16.830

5.  Telomeric armor: the layers of end protection.

Authors:  Liana Oganesian; Jan Karlseder
Journal:  J Cell Sci       Date:  2009-11-15       Impact factor: 5.285

6.  Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells.

Authors:  X Yi; J W Shay; W E Wright
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

Review 7.  The translational potential of circulating tumour DNA in oncology.

Authors:  K M Patel; D W Y Tsui
Journal:  Clin Biochem       Date:  2015-04-15       Impact factor: 3.281

8.  Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways.

Authors:  Tetsuzo Tauchi; Kazuo Shin-Ya; Goro Sashida; Masahiko Sumi; Akihiro Nakajima; Takashi Shimamoto; Junko H Ohyashiki; Kazuma Ohyashiki
Journal:  Oncogene       Date:  2003-08-14       Impact factor: 9.867

9.  POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex.

Authors:  Jeffrey Zheng-Sheng Ye; Dirk Hockemeyer; Andrew N Krutchinsky; Diego Loayza; Sarah M Hooper; Brian T Chait; Titia de Lange
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

10.  Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia.

Authors:  Delphine Poncet; Aurélie Belleville; Claire t'kint de Roodenbeke; Aude Roborel de Climens; Elsa Ben Simon; Hélène Merle-Beral; Evelyne Callet-Bauchu; Gilles Salles; Laure Sabatier; Jozo Delic; Eric Gilson
Journal:  Blood       Date:  2007-12-12       Impact factor: 25.476

View more
  13 in total

1.  Special focus on telomeres and telomerase.

Authors:  Pascal Chartrand
Journal:  RNA Biol       Date:  2016-08-02       Impact factor: 4.652

Review 2.  Telomerase RNA is more than a DNA template.

Authors:  Christopher J Webb; Virginia A Zakian
Journal:  RNA Biol       Date:  2016-05-31       Impact factor: 4.652

3.  Study of Telomere Length in Preimplanted Cultured Chondrocytes.

Authors:  Juan Manuel López-Alcorocho; Isabel Guillén-Vicente; Elena Rodríguez-Iñigo; Marta Guillén-Vicente; Tomás Fernando Fernández-Jaén; Rosa Caballero; Mercedes Casqueiro; Pilar Najarro; Steve Abelow; Pedro Guillén-García
Journal:  Cartilage       Date:  2018-01-11       Impact factor: 4.634

Review 4.  Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.

Authors:  Jixuan Gao; Hilda A Pickett
Journal:  Nat Rev Cancer       Date:  2022-07-05       Impact factor: 69.800

5.  Tying up the Ends: Plasticity in the Recognition of Single-Stranded DNA at Telomeres.

Authors:  Neil R Lloyd; Thayne H Dickey; Robert A Hom; Deborah S Wuttke
Journal:  Biochemistry       Date:  2016-09-15       Impact factor: 3.162

Review 6.  Telomeres and telomerase in prostate cancer development and therapy.

Authors:  Mindy Kim Graham; Alan Meeker
Journal:  Nat Rev Urol       Date:  2017-07-04       Impact factor: 14.432

Review 7.  Non-canonical roles of canonical telomere binding proteins in cancers.

Authors:  Semih Can Akincilar; Claire Hian Tzer Chan; Qin Feng Ng; Kerem Fidan; Vinay Tergaonkar
Journal:  Cell Mol Life Sci       Date:  2021-02-18       Impact factor: 9.261

8.  Azidothymidine "Clicked" into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors.

Authors:  Emanuela Berrino; Andrea Angeli; Dmitry D Zhdanov; Anna P Kiryukhina; Andrea Milaneschi; Alessandro De Luca; Murat Bozdag; Simone Carradori; Silvia Selleri; Gianluca Bartolucci; Thomas S Peat; Marta Ferraroni; Claudiu T Supuran; Fabrizio Carta
Journal:  J Med Chem       Date:  2020-06-10       Impact factor: 7.446

Review 9.  Therapeutic Targeting of Telomerase.

Authors:  Kathrin Jäger; Michael Walter
Journal:  Genes (Basel)       Date:  2016-07-21       Impact factor: 4.096

Review 10.  Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas.

Authors:  Elisabeth Naderlinger; Klaus Holzmann
Journal:  Genes (Basel)       Date:  2017-05-17       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.